Valsartan, a drug widely used to control blood pressure is being recalled in several countries around the world because of its chemical ingredient possibly linking to cancer.
Europe’s drugs regulator has issued a temporary staffing contract worth up to £32 million, in order to ensure it has enough hands on deck while it relocates from London as part of Brexit.